(Q37726149)

22 August 2017

1 reference

title

The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy (English)

1 reference

22 August 2017

Geoff Strange

1

1 reference

22 August 2017

Peter Nash

series ordinal

2

1 reference

22 August 2017

publication date

1 September 2009

1 reference

International Journal of Rheumatic Diseases

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

192-206

1 reference

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Long-term outcomes of scleroderma renal crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Scleroderma renal crisis: patient characteristics and long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2009.01410.X

10.1111/J.1756-185X.2009.01410.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference